Abstract| Volume 46, SUPPLEMENT 2, e24, January 2018

Chronic Mucuna pruriens in Parkinson’s disease: a non-inferiority, randomised, crossover, phase-2b trial

      Objective: Thousands of individuals with Parkinson’s disease (PD) in low-income countries remain under- treated/untreated due to unaffordability of marketed levodopa preparations. MP, a levodopa-containing leguminous plant growing in all tropical areas worldwide, may be a sustainable alternative therapy for indigent patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Parkinsonism & Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect